JSM Activity #176This is the preliminary program for the 2003 Joint Statistical Meetings in San Francisco, California. Currently included in this program is the "technical" program, schedule of invited, topic contributed, regular contributed and poster sessions; Continuing Education courses (August 2-5, 2003); and Committee and Business Meetings. This on-line program will be updated frequently to reflect the most current revisions. To View the Program: You may choose to view all activities of the program or just parts of it at any one time. All activities are arranged by date and time. |
|
The views expressed here are those of the individual authors and not necessarily those of the ASA or its board, officers, or staff. Back to main JSM 2003 Program page |
Legend: = Applied Session,
= Theme Session,
= Presenter Hotels: H = Hilton San Francisco, R = Reniassance Parc Hotel 55, N = Nikko San Francisco |
||
176 | Mon, 8/4/03, 2:00 PM - 3:50 PM | H-Continental Ballroom 7 & 8 |
Adaptive Designs and Modification of Sample Size - Contributed - Papers | ||
Biopharmaceutical Section | ||
Chair(s): Joshua Chen, Merck Research Laboratories | ||
2:05 PM | A Pragmatic Approach to Blinded Sample Size Reestimation — Anthony J. Rodgers, Merck & Co., Inc.; Norman R. Bohidar, Merck & Co., Inc.; Erluo Chen, Merck & Co., Inc. | |
2:20 PM | Optimal Conditional Error Functions for the Control of Conditional Power — Werner Brannath, University of Vienna; Peter Bauer, Instit Fur Medizinische Statistik Der Universitat Wien | |
2:35 PM | Practical Methods for Bounding Test Size with an Internal Pilot Design — Christopher S. Coffey, University of Alabama, Birmingham; Keith E. Muller, University of North Carolina, Chapel Hill | |
2:50 PM | Two-Stage Adaptive Design for Clinical Trials With Survival Data — Gang Li, Organon Inc.; Weichung J. Shih, University of Medicine and Dentistry of New Jersey; Yining Wang, University of Rochester | |
3:05 PM | Adaptive Designs for Dose Escalation Studies Using Graded Toxicities — Vladimir Dragalin, Smith Kline Beecham | |
3:20 PM | Sample Size of Randomized Designs — Feifang Hu, University of Virginia | |
3:35 PM | Properties of a Procedure to Estimate Treatment Difference and Standard Deviation with Blinded Data — Farid Kianifard, Novartis Pharmaceuticals; Michael Chen, Novartis Pharmaceuticals | |
JSM 2003
For information, contact meetings@amstat.org
or phone (703) 684-1221. If you have questions about the Continuing Education program,
please contact the Education Department. |